Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Total Current Liabilities: 2010-2025

Historic Total Current Liabilities for ProPhase Labs (PRPH) over the last 15 years, with Sep 2025 value amounting to $55.3 million.

  • ProPhase Labs' Total Current Liabilities rose 92.65% to $55.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.3 million, marking a year-over-year increase of 92.65%. This contributed to the annual value of $32.1 million for FY2024, which is 54.07% up from last year.
  • Latest data reveals that ProPhase Labs reported Total Current Liabilities of $55.3 million as of Q3 2025, which was up 115.75% from $25.6 million recorded in Q2 2025.
  • In the past 5 years, ProPhase Labs' Total Current Liabilities registered a high of $55.3 million during Q3 2025, and its lowest value of $9.9 million during Q3 2021.
  • Over the past 3 years, ProPhase Labs' median Total Current Liabilities value was $24.1 million (recorded in 2025), while the average stood at $26.1 million.
  • As far as peak fluctuations go, ProPhase Labs' Total Current Liabilities spiked by 1,525.69% in 2021, and later decreased by 18.22% in 2023.
  • Over the past 5 years, ProPhase Labs' Total Current Liabilities (Quarterly) stood at $15.5 million in 2021, then rose by 3.55% to $16.1 million in 2022, then climbed by 29.75% to $20.9 million in 2023, then surged by 54.07% to $32.1 million in 2024, then surged by 92.65% to $55.3 million in 2025.
  • Its last three reported values are $55.3 million in Q3 2025, $25.6 million for Q2 2025, and $24.1 million during Q1 2025.